Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?

被引:16
|
作者
Alizadeh, Zeinab [1 ]
Baradaran, Hamid Reza [1 ,2 ,3 ]
Kohansal, Karim [4 ]
Hadaegh, Farzad [4 ]
Azizi, Fereidoun [5 ]
Khalili, Davood [4 ,6 ]
机构
[1] Iran Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran
[2] Univ Aberdeen, Inst Appl Hlth Sci, Sch Med Med Sci & Nutr, Ageing Clin & Expt Res Team, Aberdeen, Scotland
[3] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran
[5] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran
[6] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Dept Biostat & Epidemiol, Tehran, Iran
来源
关键词
normoglycemia; pre-diabetes; type; 2; diabetes; Cardiometabolic disorders; progression; regression; NORMAL GLUCOSE REGULATION; FAMILY-HISTORY; RISK; NORMALIZATION; TOLERANCE; HEALTH; IMPACT;
D O I
10.3389/fendo.2022.1041808
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundWe aimed to determine the predictors of regression to normoglycemia and progression to diabetes among subjects with pre-diabetes in a single model concurrently. MethodsThe present study included 1329 participants aged 20 to 70 years with prediabetes from the population-based cohort of the Tehran Lipid and Glucose Study, with a 10-year follow-up. Glycemic status at follow-up was categorized as regression to normoglycemia: fasting plasma glucose [FPG] of <5.55 and 2h-plasma glucose [PG] of <7.77 mmol/L, and not taking antidiabetic medications. Glycemic status at follow-up was categorized as progression to diabetes: FPG >= 7 or 2h-PG of >= 11.1 mmol/L, or taking antidiabetic medications. Glycemic status determined whether the patients remained in prediabetes category (isolated impaired fasting glycaemia [iIFG] [(5.55 <= FPG<7 and 2h-PG<7.77 mmol/L); isolated impared glucose tolarence [iIGT] (7.77 <= 2h-PG<11.1 and FGP<5.55 mmol/L)]. With prediabetes as a reference, multinomial logistic regression was utilized to identify the determinants of glycemic changes. ResultsApproximately 40% of participants returned to normoglycemia (n = 578), and similar percentage of participants progressed to diabetes (n = 518). Based on the multivariable multinomial model, regression to normoglycemia was associated with age (relative risk ratio [RRR] = 0.97; 95% CI, 0.95-0.99), female sex (RRR = 1.72; 95% CI, 1.18-2.50), high education level of >= 12 years (RRR = 2.10; 95% CI, 1.19-3.70), and combined IFG/impaired glucose tolerance (IGT) versus IFG (RRR = 0.45; 95% CI, 0.29-0.70). The risk of progression to diabetes increased with body mass index (RRR = 1.10; 95% CI, 1.05-1.15), waist circumference (RRR = 0.97; 95% CI, 0.96-0.99), positive familial history of diabetes (RRR = 1.62; 95% CI, 1.07-2.45), and combined IFG/IGT versus IFG (RRR = 2.54; 95% CI, 1.71-3.77). ConclusionA small percentage of patients with prediabetes remain in this condition, but the majority go on to develop diabetes or regress to normoglycemia. Both directions had distinct predictors.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes
    Haffner, SM
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2006, 8 (0B) : B20 - B25
  • [32] Heterogeneity of Pre-diabetes and Type 2 Diabetes: Implications for Prediction, Prevention and Treatment Responsiveness
    Faerch, Kristine
    Hulman, Adam
    Solomon, Thomas P. J.
    CURRENT DIABETES REVIEWS, 2016, 12 (01) : 30 - 41
  • [33] New estimates of pre-diabetes and type 2 diabetes prevalence in Mexican Quintana Roo
    Zvarova, Katarina
    Zvarova, Zuzana
    Callas, Peter W.
    Malone-Rising, Dorothy
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2013, 33 (01) : 8 - 12
  • [34] New estimates of pre-diabetes and type 2 diabetes prevalence in Mexican Quintana Roo
    Katarina Zvarova
    Zuzana Zvarova
    Peter W. Callas
    Dorothy Malone-Rising
    International Journal of Diabetes in Developing Countries, 2013, 33 : 8 - 12
  • [35] Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and meta-regression
    Deyno, Serawit
    Eneyew, Kassahun
    Seyfe, Sisay
    Tuyiringire, Naasson
    Peter, Emanuel L.
    Muluye, Rekik Ashebir
    Tolo, Casim Umba
    Ogwang, Patrick Engeu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 156
  • [36] Patterns of changes in overtime working hours over 3 years and the risk for progression to type 2 diabetes in adults with pre-diabetes
    Kuwahara, Keisuke
    Miyamoto, Toshiaki
    Yamamoto, Shuichiro
    Hond, Toru
    Nakagawa, Tohru
    Mizoue, Tetsuya
    PREVENTIVE MEDICINE, 2019, 121 : 18 - 23
  • [37] Elevated cystatin C concentration and progression to pre-diabetes
    Donahue, Richard P.
    Stranges, Saverio
    Rejman, Karol
    Rafalson, Lisa B.
    Dmochowski, Jacek
    Trevisan, Maurizio
    DIABETES CARE, 2007, 30 (07) : 1724 - 1729
  • [38] Regression From Pre-Diabetes to Normal Glucose Regulation in the Diabetes Prevention Program
    Perreault, Leigh
    Kahn, Steven E.
    Christophi, Costas A.
    Knowler, William C.
    Hamman, Richard F.
    DIABETES CARE, 2009, 32 (09) : 1583 - 1588
  • [39] Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population
    Cullmann, M.
    Hilding, A.
    Ostenson, C. -G.
    DIABETIC MEDICINE, 2012, 29 (04) : 441 - 452
  • [40] Approaches to treatment of pre-diabetes and obesity and promising new approaches to type 2 diabetes
    Bloomgarden, Zachary T.
    DIABETES CARE, 2008, 31 (07) : 1461 - 1466